Gebelikte Aşılar

Englund JA. The influence of maternal immunization on infant immune responses. J Comp Pathol 2007; 137 Suppl 1:S16.

Gonik B, Fasano N, Foster S. The obstetrician-gynecologist's role in adult immunization. Am J Obstet Gynecol 2002;187:984.

Pickering LK, Baker CJ, Freed GL, et al. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:817.

Türkiye Cumhuriyeti Sağlık Bakanlığı Ulusal Aşı Portali (https://asi.saglik.gov.tr/asi-turleri.html)

5.Türkiye Cumhuriyeti Sağlık Bakanlığı Ulusal Aşı Takvimi 2025 (https://asi.saglik.gov.tr/bagisiklama-programi-ve-asi-takvimi/asi-takvimi.html)

ACOG Committee Opinion No. 741: Maternal Immunization. Obstet Gynecol 2018; 131:e214. Reaffirmed 2021. Reaffirmed 2021.

ACOG Committee Opinion No. 772: Immunization Implementation Strategies for Obstetrician-Gynecologists. Obstet Gynecol 2019; 133:e254. Reaffirmed 2022.

United States Centers for Disease Control and Prevention. Pregnancy and Vaccination: Guidelines for Vaccinating Pregnant Persons,2024.

DeSesso JM, Williams AL, Ahuja A, et al. The placenta, transfer of immunoglobulins, and safety assessment of biopharmaceuticals in pregnancy. Crit Rev Toxicol 2012; 42:185.

ACOG Committee Opinion No. 741: Maternal Immunization. Obstet Gynecol 2018; 131:e214. Reaffirmed 2021. Reaffirmed 2021.

United States Centers for Disease Control and Prevention. Vaccine safety: Thimerosal and Vaccines. (Accessed on October 08, 2024).

Keller-Stanislawski B, Englund JA, Kang G, et al. Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines. Vaccine 2014; 32:705

Centers for Disease Control and Prevention. Guidelines for vaccinating pregnant women. Atlanta (GA): CDC; 2024. 15. Centers for Disease Control and Prevention.

Vaccines recommended for pregnant women. Atlanta (GA): CDC; 2024.

T.C. Sağlık Bakanlığı. Tetanos-Difteri-Aselüler Boğmaca (Tdab) Aşı Uygulaması (PDF). Mar 13, 2025.

ACOG. Update on Immunization and Pregnancy: Tetanus, Diphtheria, and Pertussis Vaccination. Committee Opinion. Sep 2017.

Immink MM, Bekker MN, de Melker HE, et al. Maternal Pertussis Immunization and Immunoglobulin G Levels in Early- to Late-Term and Preterm Infants. JAMA Netw Open 2024; 7:e2424608.

Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025-26 Influenza Season. MMWR Morb Mortal Wkly Rep 2025; 74:500.

World Health Organization. WHO position paper on immunization to protect infants against respiratory syncytial virus disease, May 2025

FDA Approves First Vaccine for Pregnant Individuals to Prevent RSV in Infants. US Food and Drug Administration, 2023. (Accessed on October 09, 2024).

CDC recommends new vaccine to help protect babies against severe respiratory syncytial virus (RSV) illness after birth. Centers for Disease Control and Prevention, 2023.

Rottenstreich A, Zarbiv G, Oiknine-Djian E, et al. Efficient Maternofetal Transplacental Transfer of Anti- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Antibodies After Antenatal SARS-CoV-2 BNT162b2 Messenger RNA Vaccination. Clin Infect Dis 2021; 73:1909.

Kobayashi M, Farrar JL, Gierke R, et al. Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep 2022; 71:109.

Nelson NP, Weng MK, Hofmeister MG, et al. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recomm Rep 2020; 69:1.

T.C Sağlık Bakanlığı Doğum Öncesi Bakım Yönetim Rehberi.Ankara:T.C Sağlık Bakanlığı;2018.

Munoz FM. Immunization in pregnancy. In: Post TW, ed. UpToDate. Waltham (MA): UpToDate Inc. Accessed March 9, 2026.

Brenner SE, Modesitt S, Bednarczyk RA, Dilley SE. Human Papillomavirus Vaccination in the Postpartum Period: A Systematic Review. Obstet Gynecol 2024; 144:782.

American College of Obstetricians and Gynecologists' Committee on Adolescent Health Care, American College of Obstetricians and Gynecologists' Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group. Human Papillomavirus Vaccination: ACOG Committee Opinion, Number 809. Obstet Gynecol 2020; 136:e15. Reaffirmed 2023.

Das R, Blázquez-Gamero D, Bernstein DI, et al. Safety, efficacy, and immunogenicity of a replicatiodefective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial. Lancet Infect Dis 2023; 23:1383.

Diawara H, Healy SA, Mwakingwe-Omari A, et al. Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Infect Dis 2024; 24:1366.

Regan AK, et al.Systematic review and meta-analysis of interventions to increase the uptake of vaccines recommended during pregnancy. NPJ Vaccines. 2025;10:76.

Englund JA. The influence of maternal immunization on infant immune responses. J Comp Pathol 2007; 137 Suppl 1:S16.

Gonik B, Fasano N, Foster S. The obstetrician-gynecologist's role in adult immunization. Am J Obstet Gynecol 2002;187:984.

Pickering LK, Baker CJ, Freed GL, et al. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:817.

Türkiye Cumhuriyeti Sağlık Bakanlığı Ulusal Aşı Portali (https://asi.saglik.gov.tr/asi-turleri.html)

5.Türkiye Cumhuriyeti Sağlık Bakanlığı Ulusal Aşı Takvimi 2025 (https://asi.saglik.gov.tr/bagisiklama-programi-ve-asi-takvimi/asi-takvimi.html)

ACOG Committee Opinion No. 741: Maternal Immunization. Obstet Gynecol 2018; 131:e214. Reaffirmed 2021. Reaffirmed 2021.

ACOG Committee Opinion No. 772: Immunization Implementation Strategies for Obstetrician-Gynecologists. Obstet Gynecol 2019; 133:e254. Reaffirmed 2022.

United States Centers for Disease Control and Prevention. Pregnancy and Vaccination: Guidelines for Vaccinating Pregnant Persons,2024.

DeSesso JM, Williams AL, Ahuja A, et al. The placenta, transfer of immunoglobulins, and safety assessment of biopharmaceuticals in pregnancy. Crit Rev Toxicol 2012; 42:185.

ACOG Committee Opinion No. 741: Maternal Immunization. Obstet Gynecol 2018; 131:e214. Reaffirmed 2021. Reaffirmed 2021.

United States Centers for Disease Control and Prevention. Vaccine safety: Thimerosal and Vaccines. (Accessed on October 08, 2024).

Keller-Stanislawski B, Englund JA, Kang G, et al. Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines. Vaccine 2014; 32:705

Centers for Disease Control and Prevention. Guidelines for vaccinating pregnant women. Atlanta (GA): CDC; 2024. 15. Centers for Disease Control and Prevention.

Vaccines recommended for pregnant women. Atlanta (GA): CDC; 2024.

T.C. Sağlık Bakanlığı. Tetanos-Difteri-Aselüler Boğmaca (Tdab) Aşı Uygulaması (PDF). Mar 13, 2025.

ACOG. Update on Immunization and Pregnancy: Tetanus, Diphtheria, and Pertussis Vaccination. Committee Opinion. Sep 2017.

Immink MM, Bekker MN, de Melker HE, et al. Maternal Pertussis Immunization and Immunoglobulin G Levels in Early- to Late-Term and Preterm Infants. JAMA Netw Open 2024; 7:e2424608.

Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025-26 Influenza Season. MMWR Morb Mortal Wkly Rep 2025; 74:500.

World Health Organization. WHO position paper on immunization to protect infants against respiratory syncytial virus disease, May 2025

FDA Approves First Vaccine for Pregnant Individuals to Prevent RSV in Infants. US Food and Drug Administration, 2023. (Accessed on October 09, 2024).

CDC recommends new vaccine to help protect babies against severe respiratory syncytial virus (RSV) illness after birth. Centers for Disease Control and Prevention, 2023.

Rottenstreich A, Zarbiv G, Oiknine-Djian E, et al. Efficient Maternofetal Transplacental Transfer of Anti- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Antibodies After Antenatal SARS-CoV-2 BNT162b2 Messenger RNA Vaccination. Clin Infect Dis 2021; 73:1909.

Kobayashi M, Farrar JL, Gierke R, et al. Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022. MMWR Morb Mortal Wkly Rep 2022; 71:109.

Nelson NP, Weng MK, Hofmeister MG, et al. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recomm Rep 2020; 69:1.

T.C Sağlık Bakanlığı Doğum Öncesi Bakım Yönetim Rehberi.Ankara:T.C Sağlık Bakanlığı;2018.

Munoz FM. Immunization in pregnancy. In: Post TW, ed. UpToDate. Waltham (MA): UpToDate Inc. Accessed March 9, 2026.

Brenner SE, Modesitt S, Bednarczyk RA, Dilley SE. Human Papillomavirus Vaccination in the Postpartum Period: A Systematic Review. Obstet Gynecol 2024; 144:782.

American College of Obstetricians and Gynecologists' Committee on Adolescent Health Care, American College of Obstetricians and Gynecologists' Immunization, Infectious Disease, and Public Health Preparedness Expert Work Group. Human Papillomavirus Vaccination: ACOG Committee Opinion, Number 809. Obstet Gynecol 2020; 136:e15. Reaffirmed 2023.

Das R, Blázquez-Gamero D, Bernstein DI, et al. Safety, efficacy, and immunogenicity of a replicatiodefective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial. Lancet Infect Dis 2023; 23:1383.

Diawara H, Healy SA, Mwakingwe-Omari A, et al. Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Infect Dis 2024; 24:1366.

Regan AK, et al.Systematic review and meta-analysis of interventions to increase the uptake of vaccines recommended during pregnancy. NPJ Vaccines. 2025;10:76.